Accrued expenses and other current liabilities consisted of the following (in thousands):
June 30, 2026
December 31, 2025
Clinical development expenses
$
12,048
7,036
Manufacturing expenses
7,133
9,462
Compensation and related benefits
6,168
11,527
Development milestones
986
10,000
Operating lease liabilities, current portion
152
—
Other
3,230
3,626
Total accrued expenses and other current liabilities
29,717
41,651
Tabular disclosure of the components of accrued expenses and other current liabilities.
No definition available.